While we confirm that primary human GBM cells from patients express low levels of cxcr6 and cxcl16, we report that the original GBM tissues, acutely dissected from patients, over-express both cxcl16 and cxcr6, compared to human control brain tissues. This evidence concerns the gene CXCL16 and glioblastoma.